A First Generation Bisphosphnate Increases Overall Survival in Metastatic Prostate Cancer
A recent report from England, about the first-generation oral bisphosphonate sodium clodronate, claims to improve overall survival in men with metastatic but not localized prostate cancer, according to long-term data from two randomized controlled trials. [...]
Denosumab Increased Bone Mineral Density in Men With Nonmetastatic Prostate Cancer
Presented at EAU on March 23, 2009 The drug Denosumab has shown itself both easy to tolerate by patients as well highly able to increases bone mineral density (BMD) when compared with placebo in men [...]
Continious ADT vs Intermittent – There is a Winner From This Trial
One of the unsettled debates in our advanced prostate cancer world surrounds the issue of continuous vs. intermittent hormone therapy (IHT). Traditionally, hormone therapy was continuous, or once you started you never stopped the treatment. [...]
Is the Honeymoon Over? – A New Report from Scott Goodwin
That is the big question I am dealing with this week. I have been so pleased with my recent success with lowering my PSA, but the last test has reversed the trend. My PSA has [...]
Kennedy Hutchison Cancer Bill
Senators Kennedy and Hutchison introduced their long anticipated cancer bill yesterday. In summary, the bill states that: 1- Despite all the knowledge we have gained about cancer over the years, including early detection and screening, [...]
Eat that Fish
Most studies on prostate cancer prevention focus on the initial prevention of the cancer. Rarely do we see studies on preventing advanced prostate cancer. Now a study has shown that consuming omega-3 fatty acids appear [...]